Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 37,09
PER 2012
Capi. / Sales 2011 7,85x
Capi. / Sales 2012 48,7x
Capitalization 47,1 M
More Financials
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
03/31Earnings Release
More about the company
Latest news on INTELGENX TECHNOLOGIES COR
08:15a INTELGENX TECHNOLOGIES CORP. : IntelGenx Reports 2014 Annual Results and Provide..
08:13a IntelGenx Reports 2014 Annual Results and Provides Corporate Development Upda..
08:10a INTELGENX TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
08:06a INTELGENX TECHNOLOGIES : DGAP-News: IntelGenx Reports 2014 Annual Results and Pr..
03/25 INTELGENX TECHNOLOGIES : to Report 2014 Annual Results and Provide Corporate Dev..
03/23 INTELGENX TECHNOLOGIES : to Report 2014 Annual Results and Provide Corporate Dev..
03/23 INTELGENX TECHNOLOGIES : Other Events (form 8-K)
03/23 IntelGenx to Report 2014 Annual Results and Provide Corporate Development Upd..
More news
Sector news : Generic Pharmaceuticals
03:32p JOHNSON & JOHNSON : New Study Published in JAMA Psychiatry Found Three-Month Pal..
01:46p JOHNSON & JOHNSON : VIG, KBWC: Big ETF Outflows
12:29pDJShire Files 8K - Other Events
More sector news : Generic Pharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF